Detalhe da pesquisa
1.
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria.
N Engl J Med
; 387(5): 397-407, 2022 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35921449
2.
Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates.
Sci Transl Med
; 16(728): eadd5960, 2024 01 03.
Artigo
Inglês
| MEDLINE | ID: mdl-38170789
3.
Long trimer-immunization interval and appropriate adjuvant reduce immune responses to the soluble HIV-1-envelope trimer base.
iScience
; 27(2): 108877, 2024 Feb 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38318357
4.
Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
Lancet Infect Dis
; 23(5): 578-588, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36708738
5.
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.
Sci Transl Med
; 15(692): eade4790, 2023 04 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37075129
6.
IL-10 and TGF-ß Increase Connexin-43 Expression and Membrane Potential of HL-1 Cardiomyocytes Coupled with RAW 264.7 Macrophages.
Immunohorizons
; 6(6): 334-343, 2022 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35697477
7.
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial.
medRxiv
; 2022 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-35441174
8.
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.
Nat Microbiol
; 7(12): 1996-2010, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36357712